Conversely, Toor et al. (107) found that BC patients had significant elevated levels of granulocytic CD33+ CD11b+HLA-DR−/lowCD15+ MDSCs in the TME vs. surrounding healthy tissue whereas no significant differences were observed in their peripheral blood compared to healthy individuals. The gene discussed is CD33; the disease is breast cancer.